← Leaderboards
Andrei Saraiva Purysko
Case Western Reserve University
$403,583
Attributed
$1,210,749
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $609.4K · FY2024–25$1M$750K$500K$250K$0
'24
'25
Funding mix
By agency
NIH$1,210,749 · 1
By mechanism
R01$1,210,749 · 1
Top collaborators
- Emily Steinhagen3 shared
- Satish Easwar Viswanath3 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Satish Easwar Viswanath$1,285,677
- Susan Mazanec$3,204,651
- Theresa P Pretlow$1,575,823
- Graham Creasy$19,199
- Pallavi Tiwari$2,599,022
Others in their field
Other Rising Stars on “Aftercare”
- Xuping Xie · University Of Texas Med Br Galveston$10,877,958
- Michael E. Roth · Public Health Institute$8,303,012
- Leonard R. Henry · Northside Hospital Atlanta$4,036,775
- Salwa A Elgebaly · Nour Heart, Inc.$3,582,845
- Cindy S Chu · University Of Oxford$3,470,639
- Emil Schueler · University Of Tx Md Anderson Can Ctr$3,375,134
Research focus
AftercareAge GroupAgreementAsianBenchmarkingBiologicalBiologyBlack RaceBlood-Based BiomarkerCancer PatientCarcinoembryonic AntigenCaucasiansChemoradiationChemotherapyChemotherapy And/Or RadiationClinically ActionableClinical TrialsCohortCollagenComputersCostCuesDescriptorAdjuvant Chemotherapy
Grant awards (3)
Novel radiomic signatures for treatment response to neoadjuvant therapy in rectal cancers$461,643
R01 · FY2025 · CA
Novel radiomic signatures for treatment response to neoadjuvant therapy in rectal cancers$147,741
R01 · FY2025 · CA
Novel radiomic signatures for treatment response to neoadjuvant therapy in rectal cancers$601,365
R01 · FY2024 · CA